Key facts
- This page summarizes ALS Invest 1 B.V.'s Form 4 filing for Amylyx Pharmaceuticals, Inc. (AMLX).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Jul 2022, 18:44.
ALS Invest 1 B.V. - 06 Jul 2022 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- AMLX
- Reported as of
- 06 Jul 2022
- Net transaction value
- -$1,254,642
- SEC form
- 4
- Accepted by SEC
- 08 Jul 2022, 18:44:37 UTC
- Prior SEC filing
- 05 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Felix-Andre von Coerper
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Filing notes and source
Key filing fact
ALS Invest 1 B.V. filed Form 4 for Amylyx Pharmaceuticals, Inc. (AMLX) on 08 Jul 2022.
Change
- Previous filing in this sequence was filed on 05 May 2022.
- Current net transaction value: -$1,254,642.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AMLX
transaction
Common Stock
Sale
- Transaction value
- $357,816
- Shares
- -18,312
- Change %
- -0.31%
- Price
- $19.54
- Shares after
- 5,937,577
- Date
- 06 Jul 2022
- Ownership
- Direct
- Footnotes
- F1, F2
AMLX
transaction
Common Stock
Sale
- Transaction value
- $214,137
- Shares
- -10,395
- Change %
- -0.18%
- Price
- $20.60
- Shares after
- 5,927,182
- Date
- 06 Jul 2022
- Ownership
- Direct
- Footnotes
- F2, F3
AMLX
transaction
Common Stock
Sale
- Transaction value
- $630,965
- Shares
- -29,595
- Change %
- -0.5%
- Price
- $21.32
- Shares after
- 5,897,587
- Date
- 06 Jul 2022
- Ownership
- Direct
- Footnotes
- F2, F4
AMLX
transaction
Common Stock
Sale
- Transaction value
- $51,723
- Shares
- -2,307
- Change %
- -0.04%
- Price
- $22.42
- Shares after
- 5,895,280
- Date
- 06 Jul 2022
- Ownership
- Direct
- Footnotes
- F2, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
ALS Invest 1 B.V. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $19.00 to $19.975, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1), (3), (4) and (5) to this Form 4.
Footnote F2
The Reporting Person is managed by SUNU Ventures BV. Felix-Andre von Coerper is the sole corporate director of SUNU Ventures BV and has voting and dispositive power with respect to the securities held by the Reporting Person.
Footnote F3
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $20.00 to $20.99, inclusive.
Footnote F4
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $21.00 to $21.73, inclusive.
Footnote F5
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.03 to $22.655, inclusive.